NCT00835666View on ClinicalTrials.gov

Finasteride 5 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Healthy
Interventions
DRUG

Finasteride 5 mg tablets

1 x 5 mg, single dose fasting

DRUG

PROSCAR®

1 x 5 mg, single dose fasting

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835666 - Finasteride 5 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter